OCULAR HYPEREMIA
Clinical trials for OCULAR HYPEREMIA explained in plain language.
Never miss a new study
Get alerted when new OCULAR HYPEREMIA trials appear
Sign up with your email to follow new studies for OCULAR HYPEREMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drops promise redness relief in minutes
Symptom relief Not yet recruitingThis study tests a new eye drop (FID 123472) to see if it safely reduces eye redness from minor irritations in adults. About 178 participants will receive either the active drop or a placebo. The main goal is to measure redness reduction 15 minutes and 10 hours after use.
Matched conditions: OCULAR HYPEREMIA
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC
-
New eye drops aim to zap redness fast and last hours
Symptom relief Not yet recruitingThis study tests a new eye drop called FID 123472 to see if it safely reduces eye redness caused by minor irritations. About 240 adults who have used redness relief drops before will receive the drops, and doctors will measure redness at 15 minutes and 14 hours after use. The goa…
Matched conditions: OCULAR HYPEREMIA
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated May 18, 2026 12:09 UTC